Navigation Links
Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
Date:9/19/2007

ain these identifying words. The Company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to secure FDA approval for our product candidates under Section 505(b)(2) of the Federal Food, Drugs and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology; the progress or success of our research, development and clinical programs, the initiation and completion of our clinical trials, the timing of the interim analyses and the timing or success of our product candidates, particularly VIAject(TM) and VIAtab(TM); our ability to secure patents for VIAject(TM) and our other product candidates; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. The Company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.

BIOD-G


'/>"/>
SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Amendment on cloning ban rejected; vote on bill set for Wednesday
2. New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes
3. Multichannel Pipetting: How to Choose the Correct Pipettor
4. Mental research at UW-Madison could correct disabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...and, Oct. 10 /- Twenty of Britain,s m... funds and exhibit their,ideas at the fifth annual...which will be held at One Great George Street, Lon...gether the cream of technology innovators,in elect...otechnology., Six companies will give 10-minute p...
(Date:10/9/2008)...itzerland, October 10 /-, ...ife Sciences Industry, Merck Serono, a division o...that it has been named by Science magazine as a to... industries, ranking number 7 out of the,top 20 em...d that the scientific community has recognized Mer...
(Date:10/9/2008)...s Positive Operating Income Excluding Non-Cash Cha... CardioDynamics (Nasdaq:,CDIC), the innovator and ...hnology, today reported financial results for fisc...rd Quarter 2008 Compared with Third Quarter 2007 ...from $5.6 million -- International sales increase...
(Date:10/9/2008)...ion and NCPA Join Forces to Deliver Patient Care v...ro(SM), RESTON, Va. and WASHINGTON, Oct. 9 /PRNew...macists Association (APhA) Foundation, the creator...in the Asheville Project(R),jointly announced tod...,deliver all of APhA Foundation,s HealthMapRx comm...
Breaking Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3Merck Serono Named as a Top Employer by Science Magazine 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 3CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 5CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 6Mirixa Corporation and the APhA Foundation Form Partnership 2Mirixa Corporation and the APhA Foundation Form Partnership 3
... More thermostable than AMV RT and M-MLV RT ,... antiviral agents , Highly... Ideal for reverse transcribing t...ntent , Like M-MLV reverse ..., Ambion,s HIV RT synthesizes cDNA from single-str...
... Quantitate gene expression , ... 5 minute cell lysis , ...al for monitoring , siRNA-induc... with TaqMan , Gene Expression ...RT-PCR from lysate , equivalent...
... protects cellular RNA , within...pping. , Whether you are in the... you can use this aqueous, non-toxic Tissu...n Solution from ambient temperatures down to , ...cterization of disease mechanisms using , ...
...nstruction Kit , Prepare...ur , Ideal for siRNA/miRN... Synthesize high specific , ...thern, or in situ hybridization , ... , With the mir Vana miRNA ...
Other Biology Technology:Recombinant HIV Reverse Transcriptase 2Ready for Real-time in 5 Minutes 2Ready for Real-time in 5 Minutes 3Ready for Real-time in 5 Minutes 4Ready for Real-time in 5 Minutes 5Ready for Real-time in 5 Minutes 6Preserve Samples for RNA Expression Microarrays RNAlater Around the World 2Preserve Samples for RNA Expression Microarrays RNAlater Around the World 3Preserve Samples for RNA Expression Microarrays RNAlater Around the World 4Preserve Samples for RNA Expression Microarrays RNAlater Around the World 5Prepare siRNA and miRNA Probes in Just 1 Hour 2Prepare siRNA and miRNA Probes in Just 1 Hour 3
(Date:10/10/2008)...UKEE, MADISON Governor Jim Doyle today announced ...search institutions to advance personalized health...esses diseases. The Wisconsin Genomics Initiative ...field Clinic, Medical College of Wisconsin (MCW), ...lic Health (UWSMPH) and UW-Milwaukee (UWM). , Wi...
(Date:10/10/2008)... Local to Global, will be the focus of the Society... but this single event is just one small step in f...priority around the world and requires immediate a... poor nutrition, hunger and deficiencies. The Soci...embers and the public to get involved and make a d...
(Date:10/9/2008)...ct. 9 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasda...gy and biometrics software,has scheduled a confer...ts,for the third quarter of 2008 on Thursday, Octo...el Tzannes and CFO Rick Moberg will host the,earni...by Thomson and can be accessed on the,Investor Rel...
(Date:10/9/2008)...y-five years, the number of patients with compromi...risk patients such as these require a unique set o...n everything from the etiology and degree of immun...nal status. A new text from ASM Press, Diagnostic ...nes a wide range of approaches and challenges to i...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2World Food Day brings attention to food security around the globe 2Aware Announces Q3 2008 Earnings Conference Call 2Text focuses on diagnosing infections in immunocompromised patients 2Gain a Foothold on Winter Walking Safety 8931 1Marital Status Doesnt Affect Lung Cancer Survival 1121 1Marital Status Doesnt Affect Lung Cancer Survival 1121 2Marital Status Doesnt Affect Lung Cancer Survival 1121 3Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 1Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 2Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 3Grubb 26 Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield Missouri in a Joint Venture with Duke Realty 8924 4Pennsylvania Invests 2412 5 Million to Kick Off Williamsport Hospital Project 8921 1
...n, a University of Iowa anthropologist and his col... a "pygmy-sized" giant panda -- the earliest-known...h China some two million years ago. , The ancestor...anda, says Russell Ciochon, UI professor of anthro...hor of an article published in the June 18-22 onli...
...cumented the link between the way an animal moves ...an of balance, the three semicircular canals of th... article on its research will be published on 26 J... National Academy of Sciences and in the journal,s...June. , "We have shown that there is a fundament...
...ng pathway in cells that is altered by genetic mut...velopment. These new findings show how the mutati...arget for drug therapies to treat the disease. Th...s will be published June 18 in the Public Library ...kinson disease is a degenerative disorder of the c...
...onal reasons, superb starling females appear to st... according to recent Cornell research published in... , The study found that superb starling females (L...ariety of reasons. Some females mate with subordin... need help to raise their chicks. (Superb starling...
Other Biology News:UI anthropologist, colleagues discover remains of earliest giant panda 2Reconstructing the biology of extinct species: A new approach 2Researchers identify protein pathway involved in Parkinson disease development 2CU study reveals why starling females cheat 2
...s Tissue Array (MSTA) slides were designed to stud...nd tissues from multiple species. Tissue slices f...TA slide which can then be treated as a single his...stry, or in situ hybridization. This format all...
WinMelt software is used to predict the melting profile of any DNA sequence up to 3,200 bases, which aids in optimizing placement of primers and GC clamps for mutation detection by denaturing gradien
...ons RNAi Services offer you a full range of soluti...ign parameters, effective synthetic siRNA reagents...uality results from your siRNA experiments. siSolu...ary B-Algo algorithm to define siRNA sequences wit...
...96 and PowerPac basic power supply are used for su...acids in agarose gels. This Model 96 cell includes...ay with fluorescent ruler, and a gel caster. The P... provides output of 10-300 V, 4-400 mA, and 75 W. ...
Biology Products: